Understanding Equivalence and Noninferiority Testing

Understanding Equivalence and Noninferiority Testing https://t.co/3NDRyTJYTk

@DrScheuch Sie missinterpretieren die Ergebnisse: Um die Nullhypothese, so wie Sie das tun, als Effekt zu definieren, bedarf es anderer Verfahren (z.B. TOST) als die in der Studie angewendeten; siehe z.B. hier: https://t.co/flBNr2vLAQ

@DrScheuch @georgrestle Es geht nicht um Verkürzung. Sie missinterpretieren die Ergebnisse: Um die Nullhypothese, so wie Sie das tun, als Effekt zu definieren, bedarf es anderer Verfahren (z.B. TOST) als die in der Studie angewendeten; siehe z.B. hier: htt

@DrScheuch Sie missinterpretieren die Ergebnisse: Um die Nullhypothese, so wie Sie das tun, als Effekt zu definieren, bedarf es anderer Verfahren (z.B. TOST) als die in der Studie angewendeten; siehe z.B. hier: https://t.co/flBNr2vLAQ

非劣性とか同等性の検定について調べているのだけど、この有意水準の考え方が良くわからない。 https://t.co/UAdSOPiJ8A #iron勉強メモ https://t.co/PzwIEQvp1z

@Greatceasersgst @wsbgnl It has to be outside the equivalence margin for the placebo. So the 3 mcg didn’t work great in 2-5 with 2 doses, they want to test 3rd dose. But FDA could and should extend EUA on 10mcg, 2 doses to kids over 2. https://t.co/rELoG9U

@actpredictlab @lakens A one-sided equivalence test is commonly known as a non-inferiority test; see https://t.co/nhYDEx8uHe

RT @pash22: Understanding equivalence and noninferiority testing https://t.co/xVeHBuaD5D via @ClevelandClinic 's #EstebanWalker et al

Understanding equivalence and noninferiority testing https://t.co/xVeHBuaD5D via @ClevelandClinic 's #EstebanWalker et al

@jeremyfaust @First10EM Our statistics instructor in medical school wrote this amazing piece on this topic that’s super easy to follow, it’s a must read in @JournalGIM https://t.co/GnOARCdZ69

https://t.co/GNUXinK2Jq

RT @jfeldman_epi: Studies aiming to show a lack of difference are often done in an effort to make the case for a putatively riskier option.…

RT @jfeldman_epi: Studies aiming to show a lack of difference are often done in an effort to make the case for a putatively riskier option.…

RT @jfeldman_epi: Studies aiming to show a lack of difference are often done in an effort to make the case for a putatively riskier option.…

RT @jfeldman_epi: Studies aiming to show a lack of difference are often done in an effort to make the case for a putatively riskier option.…

RT @jfeldman_epi: Studies aiming to show a lack of difference are often done in an effort to make the case for a putatively riskier option.…

Studies aiming to show a lack of difference are often done in an effort to make the case for a putatively riskier option. So approaching it this way is very bad. There are more correct ways of doing it, e.g. https://t.co/RmgBp0EwBq

RT @jploenneke: Equivalence https://t.co/ZEuaT6qqDx

Equivalence https://t.co/ZEuaT6qqDx

@Sleep4Sport Not statistically significantly different is not the same thing as ‘the same’ (equivalent) https://t.co/50r72ji85D

@RaffaeleM28 This work can be interesting for your PhD Project 😜

RT @jploenneke: A paper to consider in between sessions A finding of "not different" does not necessarily mean "the same" #ACSM19 https…

RT @jploenneke: A paper to consider in between sessions A finding of "not different" does not necessarily mean "the same" #ACSM19 https…

A paper to consider in between sessions A finding of "not different" does not necessarily mean "the same" #ACSM19 https://t.co/qJzbhTdNqF

RT @ambilinski: Closing cites: Working paper w/@laura_tastic on model assumption tests https://t.co/Y1qV6CPRt8 Absence of evidence by Altma…

Understanding Equivalence and Noninferiority testing https://t.co/wG2i2YMugk

Testing for equivalence? This paper describes the super useful TOST procedure with a great commentary on the statistical method. Thanks to @FILWD for finding and sharing!

RT @FILWD: ... looks like I found it: it's "Equivalence and Noninferiority Testing" like, e.g., this: https://t.co/UgX6go2CDH.

... looks like I found it: it's "Equivalence and Noninferiority Testing" like, e.g., this: https://t.co/UgX6go2CDH.

RT @ambilinski: Closing cites: Working paper w/@laura_tastic on model assumption tests https://t.co/Y1qV6CPRt8 Absence of evidence by Altma…

RT @StevenXGe: A large P-value (>0.05) should not be interpreted as "there is no difference". It suggests the "absence of evidence of a…

A large P-value (>0.05) should not be interpreted as "there is no difference". It suggests the "absence of evidence of a difference". These are quite different statements. Maybe the sample size is not sufficient to detect a small difference.

RT @ambilinski: Closing cites: Working paper w/@laura_tastic on model assumption tests https://t.co/Y1qV6CPRt8 Absence of evidence by Altma…

RT @ambilinski: Closing cites: Working paper w/@laura_tastic on model assumption tests https://t.co/Y1qV6CPRt8 Absence of evidence by Altma…

RT @ambilinski: Closing cites: Working paper w/@laura_tastic on model assumption tests https://t.co/Y1qV6CPRt8 Absence of evidence by Altma…

RT @ambilinski: Closing cites: Working paper w/@laura_tastic on model assumption tests https://t.co/Y1qV6CPRt8 Absence of evidence by Altma…

RT @ambilinski: Closing cites: Working paper w/@laura_tastic on model assumption tests https://t.co/Y1qV6CPRt8 Absence of evidence by Altma…

RT @ambilinski: Closing cites: Working paper w/@laura_tastic on model assumption tests https://t.co/Y1qV6CPRt8 Absence of evidence by Altma…

Closing cites: Working paper w/@laura_tastic on model assumption tests https://t.co/Y1qV6CPRt8 Absence of evidence by Altman & Bland: https://t.co/HWBttL7Fms Stat sig vs Not sig by Gelman https://t.co/DQM4WiJa7M Equivalence tests by Walker & Nowack

RT @sz_dr: 差がないことを検定したいケースがちょこちょこあるので、non-inferiority testの枠組みを知っておきたい。。。 Understanding Equivalence and Noninferiority Testing https://t.c…

差がないことを検定したいケースがちょこちょこあるので、non-inferiority testの枠組みを知っておきたい。。。 Understanding Equivalence and Noninferiority Testing https://t.co/HMMRHpOMVx

RT @DrJeanneM: With tweets on recent ID outcome studies, it's a good time to know about this really interesting paper that details these of…

RT @DrJeanneM: With tweets on recent ID outcome studies, it's a good time to know about this really interesting paper that details these of…

RT @DrJeanneM: With tweets on recent ID outcome studies, it's a good time to know about this really interesting paper that details these of…

RT @DrJeanneM: With tweets on recent ID outcome studies, it's a good time to know about this really interesting paper that details these of…

RT @DrJeanneM: @TMcCarty2010 Need to read it, but did they provide a robust power calculation? Great paper illustrates how poorly these app…

With tweets on recent ID outcome studies, it's a good time to know about this really interesting paper that details these often loosely (and incorrectly) used terms. Claiming these outcomes is hard! Understanding Equivalence and Noninferiority Testing http

@TMcCarty2010 Need to read it, but did they provide a robust power calculation? Great paper illustrates how poorly these approaches are understood by many in clin research--check out table! https://t.co/6KwuaOpVzZ https://t.co/9mglgF1PjO

@Scienceofsport Interesting “guilty until proven innocent” framework. This might need a fundamental change in how ergogenic aids studies are undertaken from current superiority trial epistemology to an “equivalence trial” epistemology, https://t.co/QYseR6r

@JamesCole_Neuro @Neurosharp @Dr_J_Underwood @leechbrain @lakens You may also be interested in this article that explains ET and non-inferiority and refers to examples from HIV research: https://t.co/ev51My7uLq To me it looks that especially non-inferiori

由 null hypothesis 的觀點看這兩種研究方法的差別 這陣子研究 SEO，這樣的文章放在 search result 的第一位當之無愧！ https://t.co/51aEc4xBiC

RT @jploenneke: No difference does not imply equivalence https://t.co/qJzbhTdNqF

RT @jploenneke: No difference does not imply equivalence https://t.co/qJzbhTdNqF

RT @jploenneke: No difference does not imply equivalence https://t.co/qJzbhTdNqF

No difference does not imply equivalence https://t.co/qJzbhTdNqF

@JelkoDijkman Equivalence testing: https://t.co/89MGNAuSmo

RT @saunaksen: @UrmimalaSarkar @RussCucina This was a non-inferiority trial; low sample size is a big concern; diff approach needed https:/…

@UrmimalaSarkar @RussCucina This was a non-inferiority trial; low sample size is a big concern; diff approach needed https://t.co/sOcZvVFDjR